Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.34SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
GD.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.37.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.5.77SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FD.4.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.5.51SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
EH.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.3.2SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DF.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CK.1.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.27SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.4SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.5.16SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CM.10SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.2.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BA.5.2.25SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BQ.1.1.42SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.10SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.26SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DV.7SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.3SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
CH.1.1.11SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
FJ.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
BN.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DV.3.1SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.5.14SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
XBB.1.5.80SWon-SCTACATGCACCAGCAACTGT20502311423133F-22142.8South Korea
DV.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.10NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.26NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DV.7NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CH.1.1.11NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
FJ.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BN.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DV.3.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.14NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.5.80NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.6NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.2.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CV.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBKNNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.14.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBK.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
EF.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
CM.3NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
DF.1.1NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
BQ.1.1.35NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.2NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
XBB.1.16.8NNIH-TH_NCGTTTGGTGGACCCTCAGAT20552832028339F-22019.3Thailand
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used